INVIVO THERAPEUTICS HOLDINGS CORP. 4
4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Dec 20, 2013
Insider Transaction Report
Form 4
HESS BRIAN
CHIEF SCIENCE OFFICER
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2013-12-19+75,000→ 75,000 totalExercise: $1.95Exp: 2023-12-18→ COMMON STOCK (75,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.